Is There a Need for Change in Cancer Survivorship Care? A Qualitative Exploration of Survivor Experiences and Needs at the Sydney Cancer Survivorship Centre Clinic
Overview
Affiliations
Purpose: Effective cancer survivorship care is contingent on a comprehensive understanding and management of the dynamic needs of cancer survivors. The Sydney Cancer Survivorship Centre (SCSC) clinic established a holistic, multidisciplinary model of survivorship care. We aimed to explore survivors' experiences and perceptions of the clinic, and to identify their unmet needs.
Methods: Semi-structured focus groups (FGs) involving participants recruited from the SCSC clinic were conducted by an experienced facilitator and observer using a guide covering: survivor perceptions of first SCSC clinic visit, services accessed, ongoing unmet needs, and how needs changed over time. FGs were audio-recorded and transcribed. Interpretive description using a Framework approach was undertaken and participant characteristics summarised descriptively.
Results: Eight FGs were conducted involving a total of 26 participants (mean age: 60), most were female (n = 20), born in Australia (n = 14), and with breast cancer diagnoses (n = 16). Four overarching themes were identified: (i) perceptions of the SCSC clinic; (ii) patient-centred care; (iii) adjustment to illness; and (iv) external supports and resources. Participants valued the centralisation of multidisciplinary survivorship care at the SCSC clinic, which helped their recovery. Mitigating ongoing treatment sequelae, reassurance of good-health, normalisation of survivorship experiences, and handling caregiver stress represent some needs identified.
Conclusions: The SCSC clinic offers holistic, specialised care and reassurance to cancer survivors. Adjustment to the survivorship journey, inter-survivor shared experiences, and management of physical treatment sequelae were perceived as important in their recovery. Managing survivor needs is integral to improving long-term survivorship care.
The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer.
Kim J Endocrinol Metab (Seoul). 2024; 39(2):283-284.
PMID: 38693818 PMC: 11066438. DOI: 10.3803/EnM.2024.201.
Cortiana V, Abbas R, Nadar S, Mahendru D, Gambill J, Menon G Cancers (Basel). 2024; 16(6).
PMID: 38539549 PMC: 10969740. DOI: 10.3390/cancers16061216.